| Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children's Oncology Group PA Meyers, CL Schwartz, MD Krailo, JH Healey, ML Bernstein, D Betcher, ... Journal of clinical oncology 26 (4), 633-638, 2008 | 866 | 2008 |
| Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate PA Meyers, CL Schwartz, M Krailo, ES Kleinerman, D Betcher, ... Journal of clinical oncology 23 (9), 2004-2011, 2005 | 857 | 2005 |
| Osteosarcoma PA Meyers, R Gorlick Pediatric Clinics of North America 44 (4), 973-989, 1997 | 431 | 1997 |
| Current treatment of osteosarcoma WS Ferguson, AM Goorin Cancer investigation 19 (3), 292-315, 2001 | 397 | 2001 |
| Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial AM Goorin, MB Harris, M Bernstein, W Ferguson, M Devidas, GP Siegal, ... Journal of clinical oncology 20 (2), 426-433, 2002 | 302 | 2002 |
| Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression … D Ebb, P Meyers, H Grier, M Bernstein, R Gorlick, SE Lipshultz, M Krailo, ... Journal of clinical oncology 30 (20), 2545-2551, 2012 | 265 | 2012 |
| Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. MB Harris, P Gieser, AM Goorin, A Ayala, SJ Shochat, WS Ferguson, ... Journal of Clinical Oncology 16 (11), 3641-3648, 1998 | 248 | 1998 |
| Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial SX Skapek, WS Ferguson, L Granowetter, M Devidas, AR Perez-Atayde, ... Journal of Clinical Oncology 25 (5), 501-506, 2007 | 221 | 2007 |
| Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. SX Skapek, BJ Hawk, FA Hoffer, GV Dahl, L Granowetter, MC Gebhardt, ... Journal of clinical oncology 16 (9), 3021-3027, 1998 | 158 | 1998 |
| A phase I trial of DFMO targeting polyamine addiction in patients with relapsed/refractory neuroblastoma GL Saulnier Sholler, EW Gerner, G Bergendahl, RB MacArthur, ... PloS one 10 (5), e0127246, 2015 | 152 | 2015 |
| Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group … MB Harris, AB Cantor, AM Goorin, SJ Shochat, AG Ayala, WS Ferguson, ... Medical and pediatric oncology 24 (2), 87-92, 1995 | 135 | 1995 |
| Children’s Oncology Group. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children’s Oncology Group PA Meyers, CL Schwartz, MD Krailo, JH Healey, ML Bernstein, D Betcher, ... J Clin Oncol 26 (4), 633-638, 2008 | 101 | 2008 |
| Maintenance DFMO increases survival in high risk neuroblastoma GLS Sholler, W Ferguson, G Bergendahl, JP Bond, K Neville, D Eslin, ... Scientific reports 8 (1), 14445, 2018 | 96 | 2018 |
| Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group … WS Ferguson, MB Harris, AM Goorin, MC Gebhardt, MP Link, SJ Shochat, ... Journal of pediatric hematology/oncology 23 (6), 340-348, 2001 | 86 | 2001 |
| The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma AG Kurkchubasche, EG Halvorson, EN Forman, RM Terek, WS Ferguson Journal of pediatric surgery 35 (6), 880-883, 2000 | 82 | 2000 |
| A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma GLS Sholler, GM Bergendahl, L Brard, AP Singh, BW Heath, PM Bingham, ... Journal of pediatric hematology/oncology 33 (1), 25-30, 2011 | 56 | 2011 |
| Association of posttraumatic growth and illness‐related burden with psychosocial factors of patient, family, and provider in pediatric cancer survivors JZ Wilson, D Marin, K Maxwell, J Cumming, R Berger, S Saini, ... Journal of Traumatic Stress 29 (5), 448-456, 2016 | 53 | 2016 |
| A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma EC Lewis, JM Kraveka, W Ferguson, D Eslin, VI Brown, G Bergendahl, ... International journal of cancer 147 (11), 3152-3159, 2020 | 50 | 2020 |
| Homozygous α-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation I Thornley, L Lehmann, WS Ferguson, I Davis, EN Forman, EC Guinan Bone marrow transplantation 32 (3), 341-342, 2003 | 43 | 2003 |
| Outcomes after hematopoietic stem cell transplantation for children with I-cell disease TC Lund, SS Cathey, WP Miller, M Eapen, M Andreansky, CC Dvorak, ... Biology of Blood and Marrow Transplantation 20 (11), 1847-1851, 2014 | 39 | 2014 |
